Delivery Order SPE2DB20D3103-SPE2DB25FP8A8
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Pantoprazole Sodium delayed-release 20 mg tablets in unit dose packaging (50-count) valued at $3,463.51. The contract, which is not set-aside and utilizes firm fixed pricing, is scheduled for ultimate completion on July 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Pantoprazole Sodium delayed-release 40 mg tablets in a quantity of 1,000 units, with a ceiling value of $1,129.71. This contract represents a firm fixed-price delivery order with an ultimate completion date of July 21, 2025, and was awarded without set-aside provisions through open competition. The place of performance is AmerisourceBergen's corporate office location in...
- This federal contract award is for the delivery of PANTOPRAZOLE SOD DR 40 MG TAB 1000S medical supplies to the Defense Logistics Agency (DLA). The $1,596.92 firm fixed-price delivery order was awarded on January 29, 2025 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 30, 2025 and is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 1,000 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a ceiling value of $2,951.15 and a period of performance ending on July 9, 2025. The contract is not set aside and was awarded on July 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,120.62, is for the delivery of 4,568,142,753 units of Pantoprazole Sodium Delayed-Release 40 mg tablets in 1,000-count bottles. The contract is a firm fixed-price delivery order with a performance period ending on May 6, 2025. AmerisourceBergen Drug Corp is not a small business, and the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 40 mg Pantoprazole Sodium Delayed-Release tablets, a medication used to treat conditions such as gastroesophageal reflux disease (GERD). The contract has a ceiling value of $2,731.32 and an ultimate completion date of November 8, 2024. It is a Firm Fixed Price Delivery Order contract,...
- This federal contract award is a delivery order for $1,024.75 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of pantoprazole sodium delayed-release tablets, a generic medication used to treat conditions such as gastroesophageal reflux disease. The contract was awarded by the Defense Logistics Agency (DLA), a combat support agency of the U.S. Department of Defense, and does not have a set-aside designation,...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,059 to Amerisourcebergen Drug Corporation for 1,000 tablets of pantoprazole sodium delayed release 40 mg. The order is to be performed in Conshohocken, Pennsylvania by September 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order from its corporate office division. The Defense Logistics Agency manages the Department of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of 1,000 units of the medication Pantoprazole Sodium Delayed Release 40 mg Tablets. The contract has a ceiling value of $1,121.27 and a completion date of May 21, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8A8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Pantoprazole DR 40 mg Suspension Packets (30 count) with a ceiling value of $3,200.90. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 11, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation and represents a continuation of the company's substantial role as a pharmaceutical distributor for federal military and healthcare procurement. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen serves as a prime vendor for the Defense Logistics Agency's Medical Supply Chain, supplying a comprehensive portfolio of pharmaceutical products and medical supplies to support military healthcare systems and veteran services. The company's federal contracting profile demonstrates consistent capability in fulfilling competitive pharmaceutical procurement requirements across multiple therapeutic domains, from brand-name and generic medications to specialized medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 8/8/25 |